PCN299 - A REVIEW OF APPRAISAL TIMELINES IN ONCOLOGY- DOES REIMBURSEMENT THROUGH THE CANCER DRUGS FUND (CDF) DELAY PATIENT ACCESS?
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.381
https://www.valueinhealthjournal.com/article/S1098-3015(18)33681-7/fulltext
Section Title :
Section Order :
2287
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33681-7&doi=10.1016/j.jval.2018.09.381